Trials / Conditions / Hepatitis C Virus Infection, Response to Therapy of

Hepatitis C Virus Infection, Response to Therapy of

15 registered clinical trials studyying Hepatitis C Virus Infection, Response to Therapy of — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Unknown	Possible Differences in HCC Course Depending on DAA Treatment NCT05376943	Medical University of Warsaw	—
Completed	Rapid HCV Treatment Access for Persons Who Use Drugs NCT04677153	Johns Hopkins University	N/A
Completed	Prevention of Transmission of Hepatitis C Virus (HCV) From HCV-Viremic Organ Donor NCT04596475	University of California, San Diego	Phase 1 / Phase 2
Unknown	HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral Therapy NCT04768517	National Taiwan University Hospital	—
Unknown	HCV Reinfection in HD Patients Achieving SVR NCT04732832	National Taiwan University Hospital	—
Withdrawn	Clinical Trial to eLiminate HCV-infection in Treatment-naïve, Renally Impaired EgyptiAn Patients on Renal Dial NCT03381859	University of Maryland, Baltimore	Phase 4
Unknown	HCV Reinfection After DAA Therapy in PWID in Belgium NCT04251572	Hasselt University	N/A
Recruiting	Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional NCT05361603	University Hospital, Limoges	—
Unknown	Safety & Efficacy of Sofosbuvir 400mg/Ledipasvir 90mg in the Treatment of Chronic Hepatitis C Adolescents NCT03343444	Egyptian Liver Hospital	Phase 3
Completed	Sofosbuvir and Daclatasvir for Treating Hepatitis C in 200 Patients Co-infected With Human Immunodeficiency Vi NCT03369327	Tehran University of Medical Sciences	Phase 3
Completed	Safety and Efficacy of Generic Sofosbuvir and Ribavirin for Treatment-naive Genotype 2 Chronic Hepatitis C NCT03453346	Kawin Technology Share-holding Co., Ltd.	N/A
Completed	Generic VEL/SOF With or Without RBV for HIV/HCV Coinfected Patients NCT03250910	National Taiwan University Hospital	Phase 4
Completed	CHAMPS Study: Chronic HepAtitis C Management to ImProve OutcomeS NCT02402218	Johns Hopkins University	N/A
Unknown	Effects of Activity and Education Program on Patients With Chronic Hepatitis C Infection NCT01572233	National Taiwan University Hospital	N/A
Completed	Study to Assess Safety,Tolerability,Pharmacokinetics & Antiviral Activity of JTK-853 in Hepatitis C Virus Geno NCT01473056	Akros Pharma Inc.	Phase 1